Search Within

James H Ahn

Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Center for Hematologic Malignancies (10)
  2. GSK Faculty (10)
  3. Hematologic Malignancies Research (10)
  4. Molecular Pharmacology and Chemistry Program Faculty (10)
  5. Sloan Kettering Institute Faculty (10)
  6. Sloan Kettering Institute Postdocs (10)

More Groups

People
  1. Gabriela Chiosis (10)
  2. Tony Taldone (9)
  3. Anna Rodina Balingcongan (8)
  4. Kamalika Moulick (6)
  5. Maria Caldas Lopes- Vazquez (6)
  6. Ross Levine (6)

More People

Years
  1. 2012 (2)
  2. 2011 (4)
  3. 2010 (2)
  4. 2009 (2)
Publications
  1. Blood (3)
  2. Cancer Research (2)
  3. Assay and Drug Development Technologies (1)
  4. Bioorganic & Medicinal Chemistry (1)
  5. Journal of Clinical Investigation (1)
  6. Nature Chemical Biology (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. American Association for Cancer Research (2)
  3. American Society for Clinical Investigation (1)
  4. Mary Ann Liebert, Inc (1)
  5. National Academy of Sciences (1)
  6. Nature Publishing Group (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biochemical evidence towards the existence of an oncogenic Hsp90 complex
    Meeting Abstract

    Rodina, A.; Moulick, K.; Ahn, J.; Zong, H. L.; Cerchietti, L.; DaGama, E. G.; Caldas-Lopes, E.; Beebe, K.; Perna, F.; Hatzi, K.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
    Meeting Abstract

    Gomes-DaGama, E. M.; Moulick, K.; Ahn, J. H.; Zong, H.; Rodina, A.; Cerchietti, L.; Lopes-Vazquez, M. E. C.; Beebe, K.; Perna, F.; Katerina, C.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • FLT3-ITD+ AML blast, progenitor and stem cell populations demonstrate higher sensitivity to the HSP90 inhibitor PU-H71
    Meeting Abstract

    Zong, H. L.; Taldone, T.; Ahn, J. H.; Brennan, S.; De Leon, J. P.; Becker, M. W.; Roboz, G. J.; Chiosis, G.; Guzman, M. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
    Journal Article

    Moulick, K.; Ahn, J. H.; Zong, H.; Rodina, A.; Cerchietti, L.; Gomes DaGama, E. M.; Caldas-Lopes, E.; Beebe, K.; Perna, F.; Hatzi, K.; more...
    Nature Chemical Biology (2011)

    Fulltext@MSK | Save
  • Design, synthesis, and evaluation of small molecule Hsp90 probes
    Journal Article

    Taldone, T.; Zatorska, D.; Patel, P. D.; Zong, H.; Rodina, A.; Ahn, J. H.; Moulick, K.; Guzman, M. L.; Chiosis, G.
    Bioorganic & Medicinal Chemistry (2011)

    Fulltext@MSK | Save
  • Design of a flexible cell-based assay for the evaluation of heat shock protein 70 expression modulators
    Journal Article

    Ahn, J. H.; Luo, W.; Kim, J.; Rodina, A.; Clement, C. C.; Aguirre, J.; Sun, W.; Kang, Y.; Maharaj, R.; Moulick, K.; more...
    Assay and Drug Development Technologies (2011)

    Fulltext@MSK | Save
  • Determinants of apoptotic sensitivity to HSP90 inhibition in acute myeloid leukemia
    Meeting Abstract

    Lopes, E. C.; Gozman, A.; Taldone, T.; Ahn, J.; Marubayashi, S.; Rudin, C.; Levine, R. L.; Nimer, S.; Chiosis, G.
    Blood (2010)

    Fulltext@MSK | Save
  • HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
    Journal Article

    Marubayashi, S.; Koppikar, P.; Taldone, T.; Abdel-Wahab, O.; West, N.; Bhagwat, N.; Caldas-Lopes, E.; Ross, K. N.; Gonen, M.; Gozman, A.; more...
    Journal of Clinical Investigation (2010)

    Fulltext@MSK | Save
  • Efficacy of the novel non-quinone based HSP-90 inhibitor PU-H71 in JAK2V617F and MPLW515L-induced murine models of myeloproliferative neoplasms
    Meeting Abstract

    Koppikar, P.; Marubayashi, S.; Taldone, T.; Abdel-Wahab, O.; West, N.; Gozman, A.; Ahn, J.; Rodina, A.; Bhagwat, N.; Hedvat, C. V.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
    Journal Article

    Caldas-Lopes, E.; Cerchietti, L.; Ahn, J. H.; Clement, C. C.; Robles, A. I.; Rodina, A.; Moulick, K.; Taldone, T.; Gozman, A.; Guo, Y.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save